Lilly’s Omvoh is already recommended by NICE to treat certain cases of ulcerative colitis, another of the two main forms of ...

Sanofi has announced that it will be expanding its immunology capabilities by acquiring US-based Blueprint Medicines ...

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on ...

While sounding like an obvious statement, strategic planning is pivotal in shaping long-term success. However, given the lack ...

Pfizer has shared positive survival results from a late-stage study of its Braftovi (encorafenib) regimen in patients with ...

The key to success lies in striking the right balance: leveraging AI’s capabilities while maintaining the human elements that ...

Results presented at this year’s American Thoracic Society International Conference showed that the trials met their primary ...

‘Rise Up’ features UK spoken word poet and hip-hop artist Duke Al Durham, who also has aT1D, and is inspired by the artists’ ...

Merck & Co – known as MSD outside the US and Canada – has shared promising results from a late-stage study of its anti-PD-1 ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...

Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...

Sustainable health cannot be solved by science, clinical trial representation and access alone. It’s also down to how we live ...